Main Newsletter
Mastery Series
Therapy Series
 

Letter From The Editor

Editor's Note: Stopping Beta-cell Destruction and Team NovoNordisk

We know that type 1 diabetes results from T-cell–mediated destruction of beta-cells in the pancreas. So, to prevent type 1 diabetes from developing, we need to stop that destruction. In addition to our quest to eliminate type 1, we need to...


Letter from the Editor, #691: Health Exchanges Coming Soon

We are moving closer to the beginning of the Health Exchanges and it appears that many of the health plans will offer substantially smaller networks of hospitals and physicians than current health plans generally offer. Enrollees...


Editor's Note, SGLT2-I Issue #5

We've been bringing you these special newsletters about the SGLT2 inhibitors and hopefully they are helping you see how these new medications can be part of your patient treatment plan. For this edition, we have gone to



DCMS #150:

For the past eight years, both Steve Freed and I have been delivering CEU's on medical errors to pharmacists and nurses, and we are frequently asked what the biggest causes of errors are. After giving this considerable thought, I believe that...


Letter from the Editor #690: Can "Flipper" Help Save the Day for People with Diabetes?

There used to be a show on TV when I was a kid called "Flipper." Ranger Porter Ricks patrolled the waters around Coral Key Park with his two sons, Bud and Sandy, and their dolphin friend, "Flipper," solving crimes and spoiling...


Editor's Note, DCMS #149

This week we go back to the ADA Handbook for type 1 patients for our Clinical Text -- part 4 of our series on nutrition talks about nutrition including


Letter from the Editor, #689

Over the past months there have been a lot of articles about the idea that Alzheimer's disease may be another form of diabetes. In fact we have covered this information in previous issues of Diabetes In Control. While looking...


Editor's Note, DCMS #148

The most severe potential complication of DKA management is cerebral edema. It accounts for 60 – 90% of all DKA deaths. So if a newly diagnosed or young patient starts to slip into DKA, the proper treatment is very, very important. In...


Letter from the Editor, #688

Over and over we have new therapies for diabetes come to the market with lots of promise and hope. These new classes with great results in pre-marketing studies offer extra armament to fight the epidemic of diabetes yet they don’t get used...


Editor's Note, DCMS #147

I just finished a program in Danville, California, on hospital readmissions where I spoke to medical professionals about the high cost of readmissions and possible ways to avoid them. The program focused on using care and case managers to properly...


Letter from the Editor, #687: Sickle Cell and Diabetes

Last Monday, I was seeing patients at an endocrinologist's office and he asked us if we could see one more patient before we left. This patient was a 38 y/o African American female who had had diabetes for 3 years. Her last A1c was 6.2 but her...


Special Edition, SGLT2-Inhibitors, Editor's Desk

We have now had about three months of use of the new medication, Invokana (canagliflozin). During this time many publications including our own newsletter have been running feature stories as well as ads for the product. This delivery of...


Editor's Note, DCMS #146: New Homerun Slides on the Obesity Diabetes Epidemic

Stan Schwartz, MD, FACP, FACE has been doing clinical work for the University of Pennsylvania for many years. He has also worked with many obese patients as Director of the Obesity Program at the Cardiometabolic Diabetes Center. This week, after...


Letter from the Editor, #686: How Pharmacists Can Help with Medication Adherence

There have been a lot of additions to the diabetes drug armada over the past year and we have spent a lot of time helping you learn how best to use them. But over and over we have seen that no matter how good the drugs are, they just won't help if...


Editor's Note, DCMS #145:

If you look at the notes from the AACE conference, the AAFP conference and the recent ADA Scientific Sessions, you'll notice a lot of new algorithms for the treatment of diabetes. All this information reminds me of when I was working on improving...


Letter from the Editor, #685: Autonomic Neuropathy and Exercise

Autonomic neuropathy is damage to the central nervous system that is often caused by diabetes and can result in silent ischemia, hyperthermia, or lightheadedness with standing and during exercise. These factors make recommending physical activity...


Editor's Note, DCMS #144: Treating Calluses in Diabetic Patients

Often times when we see a diabetes patient, the first thing we look for are problems with the feet. When I meet a new patient, I always ask whether they have seen a podiatrist. These physicians specialize in problems from the tips of the toes to...


Letter from the Editor #684

Last week I wrote about a pharmacist colleague who contacted me about using long acting insulin on a prn basis. Our discussion led to the idea of starting insulin at diagnosis. Some of you commented positively on using...


Editor's Note, DCMS #143:

We often emphasize food choices for our diabetes patients and one overriding target is to decrease carbohydrates. Although this makes great sense in an overweight type 2 patient on orals, or orals and insulin, it is not necessarily as important in...


Letter from the Editor, #683: Insulin as Needed

A colleague, the director of pharmacy for a large multi-office ACO in our area, called me recently. One of his Clinical MTM pharmacists had heard from some patients who were using Lantus or Levemir as needed. He contacted me to find out if I...


Editor's Note, SGLT2-I Special Edition Issue #3

Steve, Andrew and I are back from the 73rd ADA Scientific Sessions in Chicago with lots of great information for you including many studies on current medications either showing improved outcomes or the value of using existing medications in new...


Editor's Desk, DCMS #142: DKA in Children and Adolescents

Diabetic ketoacidosis (DKA) is the leading cause of morbidity and mortality in children with type 1 diabetes mellitus and the emergency room is where the these kids usually end up. The onset of DKA can occur at anytime and can occur in children who...


Letter from the Editor #682:

This weekend finds all of us at the ADA meeting in Chicago and we have some early releases on some of the findings. The great thing about the Scientific Sessions is that researchers of new drugs, techniques and methods of diabetes care put all...


Editor's Desk, DCMS #141

We are moving closer to the full bore effect of the Affordable Care Act and although there are many opinions as to how good or bad the idea is, it has increased healthcare coverage for many Americans. Part of the program's positive ideas includes...


Letter from the Editor #681

This week I was talking to a group of physician interns about food choices for diabetes and was trying to explain the value of a low carbohydrate program. During the discussion one of the students interrupted to advise the group that eating less...


Editor's Desk, DCMS #140

I just finished a class this morning with seven patients in an endocrinologist's office. They were seven of the most diverse patients I have ever had in a class; two patients on orals, an oral and basal insulin patient, a type 2 who was dependent...


Letter from the Editor, #680: Upsides and Downsides of ACO's

We have brought you a lot of information on the emergence of Accountable Care Organizations (ACOs) as a new model...


Editor's Note, DCMS #139

Jeremy Hodson Pettus, MD, and Steven Edelman, MD are back this week to help you understand adjunctive therapies that you can use with insulin patients to improve control of A1c's, while improving weight loss success.


Letter from the Editor #679: Sheri Colberg's New Book

Sheri R. Colberg, PhD, FACSM has been writing for us for the past seven years and she is our go-to guru when it comes to anything that has to do with diabetes and physical activity. We are proud to announce that her new...


Editor's Note, DCMS #138

This week in our Homerun Slides we get back to working with medications to focus on the core defects of diabetes and how selecting the right...


Letter from the Editor #678

We are at a point with oral medications for diabetes where there are new drug approvals in recently approved classes, new drug classes where the first in class is approved, as well as late trial research moving quickly for...


Editor's Note, DCMS #137

I just finished up a two day advisory board meeting for an insulin manufacturer. We looked at some new products and studies as well as new ideas about diabetes care. Part of our discussion had to do with the increased use of EMRs (electronic...


Letter from the Editor, #677

This week I happened to run into a physician friend I had not seen for a while. While we were chatting, I noticed that he must have gotten at least six pages from his answering service. Each time he had to call in and listen to the operator...


Letter from the Editor, SGLT-2 Inhibitors, Special Edition #2

Last month, in our first issue of these special edition newsletters we gave you the tools to become an expert on SGLT2-I therapy. In our second edition we want to...


Editor's Desk, DCMS #136

We often talk about the value of controlling lipids and glucose and their relation to patient health. If patients would only do what we tell them then the results would be good and our jobs would be easier. With the recent changes in healthcare,...


Letter from the Editor #676

This past week we had our PharmD candidate, Lauren Self, scour the information from the AACE meeting in Phoenix, in order to prepare the best articles for you to review. The new AACE guidelines that Dr. Alan...


DCMS #135

Have you ever heard of 1,5-Anhydroglucitol (1,5-AG)? If not get ready to learn in this week's Homerun Slides why testing for this compound will give...


Letter from the Editor, #675

Things are in full swing at AACE this weekend and we will be bringing you the most important and usable information in next week's newsletter.    One of the most talked-about insulin-delivery products is the


DCMS #134

Last week in our Homerun Slides we started to talk about quality measures in patient care. Whenever we get information about this concept it always revolves around the practitioner, and how good a job we do, but often patient care is...


Letter from the Editor, #674

This week there is a new report out on the increased spending per year for diabetes care. This number is now well over 240 billion dollars, and when you add...



Navigate through our listing of Letter From The Editor articles here.
First Previous Next Last

603 Total articles for Letter From The Editor


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here


Cast Your Vote
Will you recommend Toujeo insulin for your patients?
CME/CE of the Week
Ronald Tamler, MD,PhD,MBA

Category: General Diabetes
Credits: .75


Advertisement


Search Articles On Diabetes In Control